Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

NCT01481220 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NETWORK

Sponsor class

Conditions

Myelodysplastic Syndrome
Thrombocytopenia

Interventions

DRUG: Eltrombopag

Sponsor

Nordic MDS Group

Collaborators

[object Object]